More Pharmaceutical Companies’ CEOs from R&D, Production Backgrounds

Published: 2004-12-07 06:56:00

Updated: 2004-12-07 06:56:00

The trend amongst the domestic pharmaceutical companies to promote their production and R&D managers to chief executive officer positions has been observed.

Ever since the separation of dispensary from medical practices has been put into effect, more domestic pharmaceutical companies are cons...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK